Nalaganje...
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...
Shranjeno v:
| izdano v: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099522/ https://ncbi.nlm.nih.gov/pubmed/34007411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9959320 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|